Adjuvant chemotherapy for stage I ovarian clear cell carcinoma: Patterns of use and outcomes
- 1 July 2018
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 150 (1), 14-18
- https://doi.org/10.1016/j.ygyno.2018.04.567
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Comparison of SEER Treatment Data With Medicare ClaimsMedical Care, 2016
- Ovarian Cancer: Diagnostic, Biological and Prognostic AspectsWomen's Health, 2014
- Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals Of Oncology, 2013
- Adjuvant Chemotherapy for Stage I Ovarian Clear Cell Carcinoma: Is it Necessary for Stage IA?International Journal of Gynecologic Cancer, 2012
- Clear cell carcinoma of the ovary: A review of the literatureGynecologic Oncology, 2012
- Adjuvant Chemotherapy for Stage I Clear Cell Carcinoma of the OvaryInternational Journal of Gynecologic Cancer, 2012
- Surgical and Medical Treatment of Clear Cell Ovarian CancerInternational Journal of Gynecologic Cancer, 2011
- Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell CarcinomasClinical Cancer Research, 2011
- Mixed Ovarian Epithelial Carcinomas With Clear Cell and Serous Components are Variants of High-grade Serous CarcinomaThe American Journal of Surgical Pathology, 2008
- Quality of Life in Ovarian Cancer Patients Receiving ChemotherapyGynecologic Oncology, 2001